# Quality Score Report: Phase 4 Cross-Pollination Synthesis — PROJ-017

## L0 Executive Summary

**Score:** 0.918/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Evidence Quality (0.89)
**One-line assessment:** The synthesis is substantively strong — all six cross-pollination tasks are addressed with depth, structured IDs are used consistently, and Phase 5 actions are specific — but two gaps prevent PASS: (1) Evidence Quality is held at 0.89 by a recurring pipeline pattern (self-assessed quality score presented as definitive in State Output YAML without external validation flag, following the same ADV-2/ADV-3B calibration issue the document itself documents), and (2) Methodological Rigor is held at 0.91 because the "pipeline confidence: HIGH" label lacks explicit criteria and the "recurring critique" classification threshold is implicit; targeted fixes to these two dimensions can reach 0.92+.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-017-llm-skill-testing/analysis/cross-pollination-synthesis.md`
- **Deliverable Type:** Cross-Pollination Synthesis (Phase 4)
- **Criticality Level:** C3 (Significant)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Scored:** 2026-03-04T00:00:00Z
- **Iteration:** 1 (first score)
- **Prior Score:** N/A (first score)
- **Agent self-assessed score:** 0.924 — NOT anchored to; scored independently

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.918 |
| **Threshold** | 0.92 (H-13) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | Yes — 5 ADV score reports referenced as prior findings |
| **Distance from Threshold** | -0.002 |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.93 | 0.186 | All 6 tasks present with depth; all 9 sources consumed; nav table H-23 satisfied; references with file paths complete |
| Internal Consistency | 0.20 | 0.93 | 0.186 | Requirements matrix 12+9=21 verified; ADV scores cross-checked against source reports; arithmetic self-review 0.924 confirmed; no factual contradictions |
| Methodological Rigor | 0.20 | 0.91 | 0.182 | Six-task structure sound; NSE-ADV bidirectional matrix rigorous; two gaps: "pipeline confidence: HIGH" criteria unstated; "recurring" pattern threshold implicit |
| Evidence Quality | 0.15 | 0.89 | 0.1335 | Structured IDs (CONV/DIV/GAP/RISK/REQ) used throughout; 9 sources with file paths; State Output YAML presents self-assessed score as definitive without external-validation flag — same pattern flagged in ADV-2 and ADV-3B; ADV-1A unrescored state reduces verifiability of its cited evidence |
| Actionability | 0.15 | 0.93 | 0.1395 | P1-P5 with specific design parameters; REQ-011 gives exact implementation pattern; requirements matrix consumable by Phase 5 agent; P4 lacks scope/owner |
| Traceability | 0.10 | 0.91 | 0.091 | Forward/backward chains via structured IDs; ADV-to-NSE and NSE-to-ADV matrices complete; two gaps: orphan RC-1 lacks resolution-owner chain; Phase 1A unrescored state leaves evidence confidence weighting undocumented |
| **TOTAL** | **1.00** | | **0.918** | |

**Arithmetic verification:** 0.186 + 0.186 + 0.182 + 0.1335 + 0.1395 + 0.091 = **0.918**

---

## Detailed Dimension Analysis

### Completeness (0.93/1.00)

**Evidence:**

All six cross-pollination tasks specified in the orchestration plan are addressed:

- **L1.1 (Technical vs. Market Convergence):** Three convergence zones and three divergence zones, each with contributing streams identified and Phase 5 implications stated.
- **L1.2 (Jerry Integration Opportunities):** Three opportunities (governance validator non-portability, quality gate dimension alignment, CLI architecture pre-design), each with Phase 1C and Phase 1B cross-reference.
- **L1.3 (ADV Critique Integration):** Summary table of all five ADV gates; three recurring patterns and two unique critiques identified.
- **L1.4 (Requirements Compliance Update):** Full 21-requirement table with Phase 2 status, V&V verdict, and updated status. MUST-HAVE and SHOULD-HAVE criteria also updated.
- **L1.5 (NSE-ADV Convergence):** NSE-to-ADV confirmation matrix (5 rows), ADV-to-Phase3B quantification matrix (5 rows), and "orphan" analysis for non-converging items.
- **L1.6 (Gap Resolution Status):** All five Phase 2 gaps tracked with Phase 3A, 3B, and ADV contributions and residual risk entering Phase 5.

L0 executive summary covers convergence pattern, five key findings, gap status, and quality trajectory. L2 provides Phase 5 implications (with explicit assumptions), requirements summary, and pipeline-level quality assessment. Navigation table covers all 11 sections with anchor links. References list all 9 input artifacts with file paths, type, key contribution, and contribution summary.

**Gaps:**

1. ADV-1B is present in the orchestration pipeline diagram but absent from the ADV Quality Gate Summary table (L1.3, lines 181-187) and the L2.3 quality trajectory table. This is consistent with the pipeline execution record (no ADV-1B score file exists in the adv/ directory), but the synthesis does not explicitly acknowledge why ADV-1B is absent. A one-sentence note ("ADV-1B was not required as Phase 1B was a pm-competitive-analyst deliverable outside the standard ADV gating path" or equivalent) would close this gap.

2. The self-review section does not include a specific anti-leniency statement — it does not document that uncertain scores were resolved downward, and does not compare self-assessed scores to calibration anchors (0.85 = strong work with minor refinements). The recurring self-review leniency pattern this document identifies in L1.3 Pattern 3 is thus ironically present in its own self-review.

**Improvement Path:**

Add one sentence explaining ADV-1B absence from the quality gate summary. Add a leniency bias check list to the self-review section with explicit downward-resolution documentation.

---

### Internal Consistency (0.93/1.00)

**Evidence:**

Requirements compliance count verification:

- L1.4 summary: "VERIFIED: 12 | PARTIAL: 9 | FAIL: 0" — 12 + 9 = 21 requirements total, consistent with Phase 3A's 21-requirement baseline.
- L2.2 summary: "VERIFIED: 12, PARTIAL (ADR-level): 8, PARTIAL (genuine gap): 1, FAIL: 0" — 8 + 1 = 9 PARTIAL, consistent with L1.4.
- REQ IDs: L1.4 lists 12 VERIFIED IDs (REQ-001 through REQ-021 subset) and 9 PARTIAL IDs — counting these against the 21 total confirms the split is accurate.

ADV score trajectory cross-checks:

- L1.3 table: "ADV-2: 0.920 (PASS, iteration 2)" — adv-2-score-v2.md confirms 0.920 PASS. Consistent.
- L1.3 table: "ADV-3A: 0.924 (PASS, iteration 3)" — adv-3a-score-v3.md confirms 0.924 PASS. Consistent.
- L1.3 table: "ADV-3B: 0.926 (PASS, iteration 3)" — adv-3b-score-v3.md confirms 0.926 PASS. Consistent.
- L2.3 quality trajectory table matches L1.3 ADV summary exactly.

Cross-section claim consistency:

- N=30 calibration study is flagged as P1 priority in L1.1 (DIVERGENCE-2), L1.3 (Recurring Pattern 1), L1.5 (NSE-to-ADV SA-1/SV-1), L1.6 (GAP-002 residual risk), and L2.1 (Assumption 1) — all consistent.
- Jerry governance validator non-portability is introduced in L1.2 Opportunity 1 and correctly referenced in L2.1 Assumption 5 — consistent.
- Self-review arithmetic: 0.186 + 0.186 + 0.184 + 0.135 + 0.140 + 0.093 = 0.924. Verified correct.

**Gaps:**

The self-review assigns Internal Consistency 0.93 with the note "No circular references or contradictions detected." This is broadly accurate, but the self-review does not acknowledge the leniency pattern it documents in L1.3 Pattern 3 as applying to its own self-review scores. The self-review does not disclaim that its own 0.924 composite is self-assessed and subject to the calibration gap it documented. This is a minor meta-level inconsistency: the synthesis identifies self-review leniency as a systematic pipeline problem (L1.3 Pattern 3, "future pipeline iterations should include an explicit anti-leniency check in self-review methodology") while its own self-review does not implement that recommendation. However, this does not create a factual contradiction — it is a philosophical inconsistency rather than a data contradiction.

**Improvement Path:**

Add a note in the self-review acknowledging that the self-assessed score is subject to the same calibration pattern documented in L1.3 Pattern 3, and that external adversarial scoring may revise it downward.

---

### Methodological Rigor (0.91/1.00)

**Evidence:**

The six cross-pollination tasks each employ a well-defined analytical structure:

- **L1.1 Convergence/Divergence:** Each zone explicitly names contributing streams, describes the mechanism by which each stream arrived at its position, and states the cross-pollination finding. The "two-pillar justification" formulation for CONVERGENCE-2 (technical authority + market confirmation) is an example of genuine synthesis methodology rather than mere juxtaposition.
- **L1.2 Jerry Integration:** Each opportunity follows a Phase 1C finding → Phase 1B finding → cross-pollination finding → Phase 3 quantification → Phase 5 implication structure, providing systematic cross-stream validation.
- **L1.3 ADV Pattern Analysis:** Distinguishes recurring patterns (appear in multiple ADV reviews) from unique critiques (appear in only one), providing a taxonomy-based analytical structure.
- **L1.4 Requirements Update:** Uses Phase 2 status as baseline, V&V verdict as update layer, and derives updated status with explicit change logic — a disciplined three-layer update protocol.
- **L1.5 NSE-ADV Bidirectional Matrix:** Two separate matrices for NSE-to-ADV and ADV-to-NSE directions, with convergence strength ratings (STRONG/MODERATE/WEAK) and mechanism descriptions. The "where V&V gaps do not align" analysis correctly identifies non-confirming items.
- **L1.6 Gap Resolution:** Each gap tracked through Phase 2 → Phase 3A → Phase 3B → ADV contributions → Resolution Status → Residual risk. This is a well-formed longitudinal tracking structure.

**Gaps:**

1. **"Pipeline confidence: HIGH" label lacks explicit criteria.** The L2.3 conclusion "pipeline confidence: HIGH" and the State Output `pipeline_confidence: HIGH` are asserted without defining what conditions would yield MEDIUM or LOW ratings. A brief statement of the criteria applied (e.g., "HIGH defined as: all MUST-HAVE criteria pass, no RED risks, all ADV deliverables PASS, no unresolved critical findings") would make this assertion methodologically rigorous.

2. **"Recurring" pattern threshold is implicit.** L1.3 labels three patterns as "recurring" — the N=30 single-source basis appears in four ADV reviews, evidence quality for competitive intelligence appears in five ADV reviews (different dimensions), and self-review inconsistency appears in two ADV reviews. The criterion for classifying a pattern as "recurring" is not defined. If two is sufficient, the threshold is low; if four is required, the two-occurrence pattern (self-review inconsistency) is borderline. This is a minor methodological gap because the pattern identification is directionally sound regardless of the exact threshold, but the implicit criterion is a rigor weakness.

**Improvement Path:**

Add a brief parenthetical to the "pipeline confidence: HIGH" label defining the applied criteria. Add a threshold note to L1.3 specifying what counts as "recurring" (e.g., "appears in >= 2 ADV review scores").

---

### Evidence Quality (0.89/1.00)

**Evidence:**

Strong citation practices throughout:

- Convergence zones cite source documents with section-level specificity: "Phase 1A, Gap Analysis section," "Phase 1B, Battle Card section," "[verification-report.md, VCRM row CONV-1]," "[risk-assessment.md, RISK-005]."
- ADV scores are cited with exact figures, iteration numbers, and specific weakest dimensions — directly verifiable against source files.
- Risk scores in L1.5 ADV-to-Phase3B matrix cite specific risk IDs with L x C = Score notation: "RISK-010 Score 12 YELLOW (Likelihood 3 Possible, Consequence 4 Major)."
- Phase 2 structured IDs (CONV-NNN, DIV-NNN, GAP-NNN) used consistently in cross-pollination findings.
- Phase 3A gap IDs (EC-1, SA-1, SV-1, RC-1) cited with risk levels in multiple sections.
- References section provides 9 sources with file paths, type, key contribution, and contribution summary — the best-practice citation standard in this pipeline.
- The synthesis explicitly discloses known evidence limitations: "Phase 1A and 1C were revised but not rescored; their final quality levels are estimated at ~0.90, not externally validated post-revision" (self-review, Evidence Quality note).

**Gaps:**

1. **State Output YAML presents self-assessed score as definitive.** The State Output YAML at line 560-591 includes `composite_quality_score: 0.924`. This is the self-assessed score from the self-review section. It is presented without any qualification that it is self-assessed or subject to external adversarial validation. The document itself documents (in L1.3 Pattern 3) that self-assessed scores in this pipeline have exceeded externally validated scores by 0.04-0.055 (ADV-2 delta: -0.055; ADV-3B delta: -0.04). Presenting the self-assessed score as the definitive composite in the machine-readable handoff YAML — without a `self_assessed: true` flag or a note that external scoring is pending — is an evidence quality gap that perpetuates the exact pattern the synthesis critiques. The external score for this deliverable (the present score report) will produce a different value, making the YAML's `composite_quality_score` field inaccurate at time of handoff.

2. **ADV-1A unrescored status creates a partial evidence gap.** The synthesis draws substantive evidence from ADV-1A findings (lines 69-71 citing "Phase 1A research score 0.90, REVISE on first iteration" and the gap claim retaining "HIGH quality status after revision"; lines 207 in L1.3 Pattern 2 describing ADV-1A competitive intelligence source concerns). ADV-1A was revised but not rescored. The synthesis estimates its post-revision quality at ~0.90 but cannot verify this. The evidence drawn from ADV-1A findings thus has an unverified confidence level. The limitation is disclosed, which reduces the severity, but it is a genuine evidence quality gap.

3. **L1.3 Pattern 3 self-review inconsistency section documents a delta for ADV-2 (self: 0.934, external: 0.879, delta -0.055).** However, the ADV-2 score v2 final score was 0.920, not the initial external score of 0.879. The delta comparison in L1.3 Pattern 3 is using ADV-2's iteration 1 external score (0.879) as the denominator against the self-review score in the final document footer (0.934), which may have been written before the v2 revision. This comparison may be mixing iteration 1 external score with a post-revision self-review score — the comparison is not clearly scoped to the same iteration, reducing evidence precision.

**Improvement Path:**

1. Add a `self_assessed: true` flag and a note `"pending_external_validation": true` to the `composite_quality_score` field in State Output YAML. Alternatively, omit the composite_quality_score from State Output until external scoring is complete.
2. Add confidence weighting notation to evidence drawn from ADV-1A findings (e.g., "ADV-1A findings at estimated ~0.90 confidence — unrescored post-revision").
3. Clarify the iteration scope in L1.3 Pattern 3's ADV-2 delta comparison: specify whether 0.879 is the iteration 1 external score and 0.934 is the pre-revision self-review score.

---

### Actionability (0.93/1.00)

**Evidence:**

The five Phase 5 priority actions are well-structured:

- **P1 (N-calibration study):** Specific design parameters — "BCa interval stability at N=10, 20, 30, 50." The cost model sensitivity analysis in L2.1 (low-N bound ~$3.50/suite at N=15, high-N bound ~$10.90/suite at N=50) provides concrete numerical guidance for Phase 5 trade study assumptions.
- **P2 (REQ-011 implementation note):** Exact implementation pattern specified — "byte-level string comparisons (.encode()), locale-independent regex (re module with ASCII flag)." This is implementation-ready specificity that Phase 5 or an implementation story can directly consume.
- **P3 (cost model update):** Specifies the date-stamping requirement and a concrete uncertainty range (±30%) plus the two-scenario framing (range rather than point estimate).
- **P4 (direct product trials):** Links to Phase 2 action item RG-1 and LES-002. The origin is traceable.
- **P5 (ADR-001 amendment):** Links to ADV-2 actionability gap and Phase 3A COMP-2 origin.

The requirements compliance matrix in L1.4 is structured for direct Phase 5 consumption — VERIFIED/PARTIAL/FAIL per requirement with explicit "Notes" column containing action items for each PARTIAL entry. The distinction between Type A (ADR-level contribution, no action needed) and Type B (genuine gap, action required before implementation) in L2.2 provides a clear decision rule for what Phase 5 needs to address vs. what is already resolved.

The Gap Resolution Status in L1.6 provides "Residual risk entering Phase 5" for each of five gaps — a directly actionable Phase 5 checklist.

**Gaps:**

P4 (direct product trials) lacks: (a) implementation scope (what specific tools to trial, what specific features to test), (b) resource estimate, (c) ownership assignment. The other four actions have enough specificity that a Phase 5 agent could act on them directly; P4 requires a sub-scoping step before execution. This is a minor weakness in an otherwise strong actionability profile.

**Improvement Path:**

Expand P4 to specify: which tools to trial (promptfoo, DeepEval, LangSmith per Phase 1B), which specific capability to test (skill-as-treatment-variable paired comparison), and the minimum evidence standard for "gap confirmed" (e.g., "unable to configure two-provider paired YAML comparison").

---

### Traceability (0.91/1.00)

**Evidence:**

Strong forward and backward traceability throughout:

- **Structured ID usage:** CONV-NNN, DIV-NNN, GAP-NNN (Phase 2), RISK-NNN (Phase 3B), SA-N, EC-N, SV-N, RC-N (Phase 3A V&V gaps), REQ-NNN, AC-NNN (Phase 1D requirements), ADV-1A/1C/2/3A/3B (quality gates) — all used consistently and cross-referenced.
- **NSE-to-ADV matrix:** Five rows mapping Phase 3A V&V gaps to specific adversarial findings with convergence strength ratings — each row names the V&V gap, its risk level, the ADV finding it corresponds to, and the ADV dimension score it affected.
- **ADV-to-Phase3B matrix:** Five rows mapping ADV attack vectors to Phase 3B risk IDs with L x C scores and mechanism descriptions — bidirectional as required.
- **Gap resolution section:** Each gap (GAP-001 through GAP-005) traced through Phase 2 status → Phase 3A contribution → Phase 3B contribution → ADV contributions → Resolution status → Residual risk. This is a complete traceability chain per gap.
- **References section:** All 9 input artifacts listed with file paths, type, and key contribution. This provides provenance for all cited sources.
- **ADV findings cited by gate ID:** "ADV-1A (lines 69-71)" etc., not attributed generically to "adversarial review."

**Gaps:**

1. **RC-1 orphan gap has an incomplete traceability chain.** L1.5 correctly identifies RC-1 (REQ-011 cross-environment determinism) as an "orphan V&V gap" that lacks adversarial validation. The synthesis recommends "Phase 5 should add an explicit verification step for REQ-011 determinism before implementation." However, it does not identify who will conduct this verification, under what Phase 5 work item, or what the acceptance criterion for "verified" is. The traceability chain for resolving RC-1 ends at "Phase 5 should add a verification step" — there is no traceable owner, work item, or acceptance criterion.

2. **Phase 1A unrescored state leaves citation confidence undocumented.** Evidence drawn from ADV-1A findings (multiple citations in L1.3 and L1.5) is acknowledged as unverified post-revision in the self-review's Evidence Quality note. However, the traceability chain for those specific citations does not carry a confidence notation. A reader following the citation chain from L1.3 Recurring Pattern 1 back to "ADV-1A (Phase 1A research score 0.90, REVISE)" cannot determine whether the evidence quality concern raised by ADV-1A was addressed in the revision. The disclosure exists in the self-review but is not propagated into the citation points themselves.

**Improvement Path:**

For RC-1, add a P3 action in L2.1 or L1.5 specifying who adds the Phase 5 verification step and what the acceptance criterion is. For Phase 1A citations, add a brief inline caveat at the point of citation (e.g., "[ADV-1A, unrescored post-revision; ~0.90 estimated]") to propagate the confidence limitation into the traceability chain.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Evidence Quality | 0.89 | 0.92 | Add `self_assessed: true` and `pending_external_validation: true` flags to State Output YAML `composite_quality_score` field, OR omit score until external validation. Add confidence caveat to ADV-1A citations in L1.3/L1.5. Clarify ADV-2 delta comparison scope in L1.3 Pattern 3 (iteration 1 external score vs. post-revision self-review). |
| 2 | Methodological Rigor | 0.91 | 0.93 | Add explicit criteria for "pipeline confidence: HIGH" label (one parenthetical). Add threshold note to L1.3 for "recurring" pattern classification (one sentence: "appears in >= 2 ADV reviews"). |
| 3 | Traceability | 0.91 | 0.93 | Add owner/acceptance-criterion to RC-1 orphan gap resolution path in L1.5 or L2.1. Propagate Phase 1A confidence caveat inline at citation points. |
| 4 | Completeness | 0.93 | 0.94 | Add one sentence explaining ADV-1B absence from quality gate summary. Add anti-leniency check to self-review section. |
| 5 | Internal Consistency | 0.93 | 0.94 | Add self-review note acknowledging the self-assessed composite is subject to the calibration pattern documented in L1.3 Pattern 3. |

**Minimum fixes to reach PASS (0.92):** Priority 1 (Evidence Quality) and Priority 2 (Methodological Rigor) together bring the composite to approximately 0.926. Both are targeted documentation additions — no structural changes required.

---

## Anti-Anchoring Note

The agent self-assessed this deliverable at 0.924 (self-review, line 528). This independent external score is **0.918**, a delta of -0.006. This delta is consistent with the self-review leniency pattern documented in the deliverable itself (ADV-2: delta -0.055; ADV-3B: delta -0.04 on Internal Consistency). The cross-pollination synthesis correctly identifies self-review score inflation as a systemic pipeline pattern, and the 0.006 gap confirms it persists in the Phase 4 deliverable as well. The two dimensions most affected by independent scoring vs. self-assessment:

- **Methodological Rigor:** Self-assessed 0.92, externally scored 0.91 — driven by two implicit methodological standards ("HIGH" confidence criteria, "recurring" threshold)
- **Evidence Quality:** Self-assessed 0.90, externally scored 0.89 — driven by the State Output YAML self-assessed score presentation pattern and ADV-1A unrescored citation gap

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing composite — scoring process above documents evidence and score separately per dimension
- [x] Evidence documented for each score — specific line numbers, quoted text, cross-referenced source reports cited per dimension
- [x] Uncertain scores resolved downward — Evidence Quality uncertain between 0.89 and 0.90, resolved to 0.89; Methodological Rigor uncertain between 0.91 and 0.92, resolved to 0.91; Traceability uncertain between 0.91 and 0.92, resolved to 0.91
- [x] Not a first draft — this is Phase 4 of a structured C3 pipeline with self-review applied; scores in the 0.89-0.93 range are appropriate for this production stage
- [x] No dimension scored above 0.95 without exceptional evidence — highest scores are Completeness, Internal Consistency, and Actionability at 0.93
- [x] Self-assessed score (0.924) NOT used as anchor — independent scoring produced 0.918, delta -0.006, driven by specific documented gaps
- [x] Calibration check: 0.918 is in the "REVISE — near threshold, targeted improvements" band. This is consistent with a document that is substantively excellent (all cross-pollination tasks addressed with depth, structured citations throughout) but has two targeted documentation quality gaps that prevent PASS. The REVISE verdict is warranted; the document is close to PASS, not far from it.

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.918
threshold: 0.92
weakest_dimension: Evidence Quality
weakest_score: 0.89
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "P1 (Evidence Quality): Add self_assessed:true and pending_external_validation:true flags to State Output YAML composite_quality_score — the self-assessed score presented as definitive perpetuates the leniency pattern the document itself identifies in L1.3 Pattern 3"
  - "P2 (Methodological Rigor): Add explicit criteria for 'pipeline confidence: HIGH' label (one parenthetical defining the conditions); add threshold note for 'recurring' pattern classification in L1.3"
  - "P3 (Traceability): Add owner/acceptance-criterion to RC-1 orphan gap resolution path; propagate Phase 1A confidence caveat at citation points in L1.3/L1.5"
  - "P4 (Completeness): Add one sentence explaining ADV-1B absence from quality gate summary table; add anti-leniency check to self-review section"
  - "P5 (Internal Consistency): Add self-review note acknowledging self-assessed composite is subject to the calibration pattern documented in L1.3 Pattern 3"
minimum_fixes_for_pass: "P1 + P2 are sufficient to raise composite to ~0.926. Both are targeted documentation additions. No structural revisions required."
distance_from_threshold: -0.002
anti_anchoring_note: "Self-assessed 0.924; external independent score 0.918; delta -0.006. Consistent with documented pipeline self-review leniency pattern (ADV-2 delta -0.055, ADV-3B IC delta -0.040)."
```

---

*Score Report produced: 2026-03-04T00:00:00Z*
*Agent: adv-scorer*
*Strategy: S-014 (LLM-as-Judge) with 6-dimension SSOT rubric*
*SSOT: `.context/rules/quality-enforcement.md`*
*Deliverable self-assessment: 0.924 | Independent score: 0.918 | Delta: -0.006*
*Prior ADV scores referenced: adv-3a-score-v3.md (0.924 PASS), adv-3b-score-v3.md (0.926 PASS), adv-2-score-v2.md (0.920 PASS)*
*Score cross-checks: ADV-2 (0.920), ADV-3A (0.924), ADV-3B (0.926) verified against source score reports*
